Repros Therapeutics (RPRX) Boss Steps Down, Interim CEO Named
02 Feb 2017 //
BIOSPACE
FDA Grants End of Phase 2 Meeting to Discuss Ph3 Requirements for Oral Proellex
30 Jan 2017 //
GLOBENEWSWIRE
Repros Requests Meeting With FDA to Discuss Ph3 Requirements for Proellex
19 Dec 2016 //
GLOBENEWSWIRE
Repros to drop testosterone drug in U.S. if key study fails
15 Apr 2016 //
REUTERS